Omeros reported $8.84M in Trade Creditors for its fiscal quarter ending in June of 2025.





Trade Creditors Change Date
Adma Biologics USD 31.72M 11.2M Jun/2026
Alnylam Pharmaceuticals USD 108.02M 18.61M Jun/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Cytokinetics USD 20.51M 4.2M Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
Heron Therapeutics USD 11.64M 2.67M Jun/2026
Immunic USD 11.01M 873K Mar/2026
Insmed USD 74.55M 1.18M Jun/2026
Knight Therapeutics CAD 125.76M 7.63M Dec/2025
MacroGenics USD 3.44M 845K Jun/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 17.51M 3.5M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Rockwell Medical USD 1.5M 423K Jun/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026